Monitoring

Photo

Achieving HbA1c target values

An adequate blood glucose level (4–7 mmol/l) is important not only for a diabetic’s daily well-being but also to prevent diabetes-related illnesses. HbA1c is the central marker to evaluate the success of diabetes management. But HbA1c measurement has a crucial limitation: current blood glucose fluctuations are not taken into consideration. However, the recognition of steep post-prandial blood…

Photo

The Renewing Health European project

Renewing Health is the Veneto Region’s response to the third Call of Proposals by the European Information Communication Technology Policy Support Programme (ICT-PSP). The project, which falls under the ICT-PSP financing plans, aims to facilitate the use of ICT-based solutions and services for citizens, the government, and businesses, as well as aiding their diffusion throughout Europe.

Patient monitoring devices

In 2009, the continuous glucose monitoring (CGM) market earned manufacturers $23.5; this is forecast to reach $52.0 million in 2016, according to a new analysis from Frost and Sullivan (F&S). For the study the markets covered by region are Benelux, Germany, France, Italy, Scandinavia, Spain and the United Kingdom.

Photo

Self-monitoring of blood glucose

Around 75% of adult type 1 and type 2 diabetics say they believe they know what their blood sugar levels are, without testing, according to data presented at the American Diabetes Association 70th Scientific Sessions. These results are important to consider because self-monitoring with a blood glucose meter is essential for people with diabetes to obtain accurate blood glucose results that guide…

Endocrine Society: No change in blood sugar control goals

A study published this week in Lancet suggests that low A1C levels may be just as dangerous as high A1C levels in diabetes patients with respect to mortality and cardiovascular outcomes. Upon review of the study, The Endocrine Society released a statement recommending against any wholesale change in glycemic goals and strongly encourages patients to discuss these issues with their diabetes-care…

Photo

PET/CT Predicts Early Response to Chemotherapy

That wait time might be shortened for patients with soft-tissue sarcomas thanks to new research, from the Jonsson Comprehensive Cancer Center at the University of California, Los Angeles (UCLA), demonstrating that PET/CT can be used as early as one week after a single treatment cycle to determine whether the drugs are killing the cancer. Researchers made another surprising discovery—some tumors…

Photo

Monitoring CHF patients

Close monitoring of vital signs such as ECG, BP and body weight are vital for many patients suffering cardiovascular disease. MyHeart, an integrated project involving 10 EU Member States, aims to produce better devices and better parameters than currently available, i.e. traditional sensor systems with digital upgrades. The ongoing clinical study has involved six European academic centres and 200…

Photo

Large capacity intensive care ambulances

In March 2008 over 200 cars were involved in a mass traffic accident caused by fog between Abu Dhabi and Dubai. Six passengers were killed; hundreds were injured. Similar road traffic accidents, airplane crashes on the most frequented hub in the region and fires in factories and skyscrapers are among the mass casualty events that the Dubai Centre of Ambulance Services face on a daily basis.

Photo

A better way to take temperature

The temporal artery thermometer was developed in response to the clinical requirements for a truly non-invasive, accurate method of taking temperature. GE now offers, in Germany and Middle-East, the Exergen handheld temporal artery thermometer TAT 5000, which provides several benefits including accuracy, ease of use and cost effectiveness.

Photo

Patient monitoring as part of the HIS

This October GE Healthcare launched its new Carescape Monitor B 850 at the 22nd Congress of the European Society of Intensive Care Medicine (ESICM). Resulting from the expertise optimised in recent years through the acquisition of Datex Ohmeda and Marquette Electronics, the result is a successful integration of the patient monitoring platform with the inclusion of the hospital information systems…

Photo

The Isolette 8000

The new Isolette 8000 is the latest model in Dräger’s respected Isolette series of infant incubators that introduced innovations such as the patented Dual Air Curtain, known from the Isolette C2000. ‘This thermal management capability, which is also part of the Isolette 8000, reduces radiant heat loss from the infant and contributes to a cocoon-like environment, where the neonate can…

Biochips to aid in cancer diagnosis

It is very difficult to predict whether a cancer drug will help an individual patient: only around one third of drugs will work directly in a given patient. Researchers at the Heinz Nixdorf Chair for Medical Electronics at the Technische Universitaet Muenchen (TUM) have developed a new test process for cancer drugs. With the help of microchips, they can establish in the laboratory whether a…

Photo

Enjoying childhood - despite being a type 1 diabetic

Type 1 diabetes is a life-long autoimmune disease with onset in early childhood. The diagnosis will initially turn the everyday life of children and their families topsy-turvy due to blood glucose testing, insulin injections, thorough calculation of meals, etc. It takes time before all these new and often frightening procedures become part of the daily routine of small diabetics.

Photo

CARDIOVIT CS-200 - new design and additional features

CS-200: SCHILLER´s complete Diagnostic Solution has been redesigned, offering now even more added value. Discreet but important external modifications encompass a large, swivel-mounted 19`` monitor, as well as an ergonomic design. A new, simplified user-interface as well as various new holders and mounting kits for external devices such as gel bottles, bar code scanners, spirometry sensors and…

Futures: HIV self-monitoring

HIV/AIDS has reached pandemic proportions. 35 million people are infected. Given the situation of hard pressed general practitioners (GPs) today, as well as geographical and other difficulties (as in Africa, for example), a new device that will enable HIV patients to monitor their own health and the effectiveness of treatments, without visiting their doctors so often, is indeed promising.

122 show more articles
Subscribe to Newsletter